Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children
Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection
Treatment of Drug-Susceptible Tuberculosis
Executive SummaryExternalexternal icon
Full GuidelinesExternalexternal icon
Clinical Infectious Disease 2016
-
Table 3. Doses of Antituberculosis Drugs for Adults and ChildrenExternalexternal icon
-
Highlights from the 2016 Treatment of Drug-Susceptible Tuberculosis Guidelines
Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis
June 2013
Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis 2013
Treatment of Drug-Resistant Tuberculosis
American Journal of Respiratory and Critical Care Medicine, 2019
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIVexternal icon
2018
Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescentsexternal icon
2017
Treatment of Drug-Susceptible Tuberculosisexternal icon
Clinical Infectious Disease 2016
-
Table 3. Doses of Antituberculosis Drugs for Adults and Childrenexternal icon
-
Highlights from the 2016 Treatment of Drug-Susceptible Tuberculosis Guidelines
Tuberculosis, Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019.
Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection
MMWR 2018; 67:723-726
Diagnosis of Tuberculosis in Children and Adultsexternal icon
Clinical Infectious Disease 2017
Treatment of Drug-Susceptible Tuberculosisexternal icon
Clinical Infectious Disease 2016
Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis
Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis
MMWR 2013; 62 (No. 9)
Availability of an Assay for Detecting Mycobacterium tuberculosis, Including Rifampin-Resistant Strains, and Considerations for Its Use — United States, 2013
MMWR 2013; 62 (No. 41)